Lupin launches drugs to cure leukaemia Lupin launches drugs to cure leukaemia Amir Shaikh / Tuesday, July 9, 2019 / Article rating: 5.0 Pharma major Lupin informed the bourses that it has launched Imatinib Mesylate Tablets, 100 mg (base) and 400 mg (base). It is a chemotherapy drug that works by slowing or stopping the growth of cancer cells.
Ten stocks close to their 52-weeks low Ten stocks close to their 52-weeks low Shital Jibhe / Tuesday, July 9, 2019 / Article rating: 5.0 Following stocks are close to their 52-weeks low as at 2:08 p.m. on July 09, 2019.
Ten stocks close to their 52-weeks high Ten stocks close to their 52-weeks high Shital Jibhe / Tuesday, July 9, 2019 / Article rating: 5.0 The markets on July 09, 2019 opened gap down. BSE Sensex is trading at 38,672.61, down by 47.96 points and the Nifty is trading at 11,532.40, down by 26.20 points.
Meghmani Organics starts commercial operation of CMS project Meghmani Organics starts commercial operation of CMS project Nidhi Jani / Tuesday, July 9, 2019 / Article rating: 3.6 Expansion of MDC would help the company to meet the growing demand of pharma and agrochemical customers, while Chloroform will meet demand for raw material in the pharma sector and refrigerant gas segment.
Voltas enters partnership with EESL for 5 star ACs Voltas enters partnership with EESL for 5 star ACs Pratik Shastri / Tuesday, July 9, 2019 / Article rating: 3.5 India’s leading AC manufacturer, Voltas Limited announced that it has entered into a partnership with Energy Efficient Services Limited (EESL) for production of energy efficient air conditioners.
Can large and mid-cap funds help you buy your dream car? Can large and mid-cap funds help you buy your dream car? Henil Shah / Tuesday, July 9, 2019 / Article rating: 3.7 We all have various financial goals and we try to achieve all of them. So, can large and mid-cap funds help you to achieve your goal of buying a dream car?
Glenmark Pharma gets ANDA approval for Ranolazine Glenmark Pharma gets ANDA approval for Ranolazine Geyatee Deshpande / Tuesday, July 9, 2019 / Article rating: 5.0 Glenmark Pharmaceuticals Inc. has received final approval from United States Food & Drug Administration (USFDA) for Ranolazine Extended-Release Tablets, 500 mg and 1,000 mg.
Mutual Funds Unlocked: Fundamental analysis of funds Mutual Funds Unlocked: Fundamental analysis of funds Shashikant Singh / Tuesday, July 9, 2019 / Article rating: 4.5 Mutual fund schemes are generally analysed from its historical price and returns, however they can and should be fundamentally analysed to make appropriate investment decesion.
Titan nose dives post Q1 business update Titan nose dives post Q1 business update Amir Shaikh / Tuesday, July 9, 2019 / Article rating: 4.7 The Titan Industries presented its business update for the first quarter of FY20. The company is experiencing the pressure of consumption slowdown and higher gold prices are also adding to the pain. The company’s growth was lower than what was projected.
Five stocks with selling interest Five stocks with selling interest Shital Jibhe / Tuesday, July 9, 2019 / Article rating: 5.0 Overall volumes in futures & options currently stand at 1,61,47,776 contracts with a turnover of Rs.11,60,082.76 crore.